Structure

InChI Key FABPRXSRWADJSP-MEDUHNTESA-N
Smile COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
InChI
InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H24FN3O4
Molecular Weight 401.44
AlogP 2.37
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 4.0
Polar Surface Area 83.8
Molecular species ZWITTERION
Aromatic Rings 2.0
Heavy Atoms 29.0

Pharmacology

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Bacterial Infections 4 D001424 ClinicalTrials
Eye Infections 4 D015817 ClinicalTrials
Otitis Media 3 D010033 ClinicalTrials
Cellulitis 3 D002481 ClinicalTrials
Tuberculosis 3 D014376 ClinicalTrials
Pneumonia 3 D011014 ClinicalTrials
Abscess 3 D000038 ClinicalTrials
Infections 3 D007239 ClinicalTrials
Bronchitis, Chronic 3 D029481 ClinicalTrials
Otitis Externa 3 D010032 ClinicalTrials
Pneumonia, Bacterial 3 D018410 ClinicalTrials
Conjunctivitis, Bacterial 3 D003234 ClinicalTrials
Cataract 3 D002386 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Endophthalmitis 3 D009877 ClinicalTrials
Skin Diseases 3 D012871 ClinicalTrials
Sinusitis 3 D012852 ClinicalTrials
Tuberculosis, Pulmonary 3 D014397 ClinicalTrials
Cholecystitis, Acute 3 D041881 ClinicalTrials
Pelvic Inflammatory Disease 3 D000292 ClinicalTrials
Inflammation 3 D007249 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 3 D029424 ClinicalTrials
Tuberculosis, Multidrug-Resistant 2 D018088 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Meningitis 2 D008581 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Tuberculosis, Multidrug-Resistant 2 D018088 ClinicalTrials
Parkinson Disease 2 D010300 ClinicalTrials
Cholangitis 2 D002761 ClinicalTrials
Muscle Spasticity 2 D009128 ClinicalTrials
Lupus Erythematosus, Systemic 1 D008180 ClinicalTrials
Dyspepsia 1 D004415 ClinicalTrials
Cardiotoxicity 1 D066126 ClinicalTrials
Influenza, Human 1 D007251 ClinicalTrials
Lice Infestations 1 D010373 ClinicalTrials
Hypotension, Orthostatic 1 D007024 ClinicalTrials
Nausea 1 D009325 ClinicalTrials
Schizophrenia 1 D012559 ClinicalTrials
Acute Coronary Syndrome 1 D054058 ClinicalTrials
Diabetes Mellitus, Type 2 1 D003924 ClinicalTrials
Hepatitis C 1 D006526 ClinicalTrials
Lung Diseases 1 D008171 ClinicalTrials
Amyotrophic Lateral Sclerosis 1 D000690 ClinicalTrials
Carcinoma, Renal Cell 1 D002292 ClinicalTrials
Arthritis, Rheumatoid 1 D001172 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials
Premature Birth 1 D047928 ClinicalTrials
Fibromyalgia 1 D005356 ClinicalTrials
Malaria, Vivax 1 D016780 ClinicalTrials
Restless Legs Syndrome 1 D012148 ClinicalTrials
Constipation 1 D003248 ClinicalTrials
Alzheimer Disease 1 D000544 ClinicalTrials
Epilepsy 1 D004827 ClinicalTrials
Pain 1 D010146 ClinicalTrials
Erectile Dysfunction 1 D007172 ClinicalTrials
Lipid Metabolism Disorders 1 D052439 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials
Phenylketonurias 1 D010661 ClinicalTrials
Asthma 1 D001249 ClinicalTrials
Hypertension 1 D006973 ClinicalTrials
Acquired Immunodeficiency Syndrome 1 D000163 ClinicalTrials
Coronary Disease 1 D003327 ClinicalTrials
Anemia 1 D000740 ClinicalTrials
Psychotic Disorders 1 D011618 ClinicalTrials
Diabetes Mellitus 1 D003920 ClinicalTrials
Heart Failure 1 D006333 ClinicalTrials
Hypoglycemia 1 D007003 ClinicalTrials
Respiratory Tract Infections 1 D012141 ClinicalTrials
Immune System Diseases 1 D007154 ClinicalTrials
Osteomyelitis 0 D010019 ClinicalTrials

Related Entries

MCS

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 151096-09-2
ChEBI 63611
ChEMBL CHEMBL32
DrugBank DB00218
DrugCentral 1854
EPA CompTox DTXSID3048491
FDA SRS U188XYD42P
Human Metabolome Database HMDB0014363
Guide to Pharmacology 10915
PDB MFX
PharmGKB PA450555
PubChem 152946
SureChEMBL SCHEMBL24007
ZINC ZINC000003826253